Irena Ivanovska joined The Mark Foundation as Senior Scientific Director in April 2021. Prior to that, she was Director and Site Head at Celdara Medical where she led company expansion into the Boston/Cambridge biotech ecosystem, and was instrumental in shaping company strategy and scientific direction. At Celdara, she led preclinical development teams for small and large molecule therapeutics in oncology and infectious disease. Before joining Celdara, Irena led R&D teams at Merck & Co., Inc., in oncology and autoimmune diseases. Irena received a PhD in Molecular Biology from Princeton University and completed her postdoctoral training at the Whitehead Institute. She serves as a mentor to young scientists and budding entrepreneurs, and is co-author on multiple scientific papers in diverse disease areas.